Cargando…

Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: a randomized controlled trial

BACKGROUND: Intensive glucose control reduces the risk for microvascular complications in type 2 diabetes (T2DM). Recently, sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to exert renoprotection beyond glycemic control, although their effects on the organs are not well known. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satirapoj, Bancha, Korkiatpitak, Pattharamon, Supasyndh, Ouppatham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Sglt2 Inhibitors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543969/ https://www.ncbi.nlm.nih.gov/pubmed/31198224 http://dx.doi.org/10.1093/ckj/sfy122

Ejemplares similares

Sodium-glucose cotransporter inhibitors: beyond glycaemic control
por: Vergara, Ander, et al.
Publicado: (2019)

How can sodium–glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron‐deficient? Implications for understanding iron homeostasis in heart failure
por: Packer, Milton
Publicado: (2022)

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2019)

Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

Dapagliflozin's effect on serum homocysteine in patients with hypertension complicated with insulin resistance
por: Yu, Xiaoqian, et al.
Publicado: (2023)

SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
por: Lim, Ven G., et al.
Publicado: (2019)

Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
por: Connelly, Kim A., et al.
Publicado: (2019)

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
por: Herrington, William G, et al.
Publicado: (2018)

Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study
por: Satirapoj, Bancha, et al.
Publicado: (2016)

Periostin as a Tissue and Urinary Biomarker of Renal Injury in Type 2 Diabetes Mellitus
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR study
por: Kario, Kazuomi, et al.
Publicado: (2020)

Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA study
por: Okada, Kenta, et al.
Publicado: (2020)

Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
por: Yongwatana, Kachonsak, et al.
Publicado: (2020)

Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study
por: Singhsakul, Amol, et al.
Publicado: (2019)

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Electrolyte disturbances and risk factors of acute kidney injury patients receiving dialysis in exertional heat stroke
por: Satirapoj, Bancha, et al.
Publicado: (2016)

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Clinicopathological Correlation in Asian Patients with Biopsy-Proven Lupus Nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Efficacy and safety of subcutaneous administration of lyophilized powder of alfa-erythropoietin to maintain hemoglobin concentrations among hemodialysis patients
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Very low protein diet plus ketoacid analogs of essential amino acids supplement to retard chronic kidney disease progression
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Arterial Stiffness Predicts Rapid Decline in Glomerular Filtration Rate Among Patients with High Cardiovascular Risks
por: Satirapoj, Bancha, et al.
Publicado: (2020)

Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial
por: Siriwattanasit, Narongrit, et al.
Publicado: (2021)

Impaired Glomerular Filtration Rate in Type 2 Diabetes Mellitus Subjects: A Nationwide Cross-Sectional Study in Thailand
por: Nata, Naowanit, et al.
Publicado: (2020)

The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population
por: Satirapoj, Bancha, et al.
Publicado: (2013)

The effect of ONCE Renal on minerals and electrolytes in predialysis patients with chronic kidney disease
por: Satirapoj, Bancha, et al.
Publicado: (2016)

Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Efficacy of Weekly Split versus Single Doses of Ergocalciferol on Serum 25-Hydroxyvitamin D among Patients on Continuous Ambulatory Peritoneal Dialysis: A Randomized Controlled Trial
por: Nata, Naowanit, et al.
Publicado: (2021)

Efficacy of Lactulose versus Senna Plus Ispaghula Husk Among Patients with Pre-Dialysis Chronic Kidney Disease and Constipation: A Randomized Controlled Trial
por: Nata, Naowanit, et al.
Publicado: (2021)

Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease
por: Nata, Naowanit, et al.
Publicado: (2023)

Deconvoluting Kinase Inhibitor Induced Cardiotoxicity
por: Lamore, Sarah D., et al.
Publicado: (2017)

Nutritional status among peritoneal dialysis patients after oral supplement with ONCE dialyze formula
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Effects of sodium‐glucose cotransporter 2 inhibitor, tofogliflozin, on the indices of renal tubular function in patients with type 2 diabetes
por: Nunoi, Kiyohide, et al.
Publicado: (2018)

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus
por: Choi, Y, et al.
Publicado: (2023)

Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
por: Cavaiola, Tricia Santos, et al.
Publicado: (2018)

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
por: Sano, Motoaki
Publicado: (2017)

Renal outcomes with sodium-glucose cotransporters 2 inhibitors
por: Sun, Xiaoya, et al.
Publicado: (2022)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
por: Tang, Jun, et al.
Publicado: (2022)

Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure
por: Reed, James W
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0ch67r88ks5t2rjtnnffq2eqrr